Vir Biotechnology (MEX:VIR) Growth Rank: 1 (As of Aug. 19, 2026) — 50% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:VIR Vir Biotechnology Inc MEX:VIR
52 GF Score
Price MXN170.00
GF Value MXN764.28
! 5 Warning Signs
View Full Analysis

What is Vir Biotechnology Growth Rank?

Vir Biotechnology MEX:VIR 52 Growth Rank is 1 as of Aug. 19, 2026, which is 50% below its 10-year median of 2.00. GuruFocus rates MEX:VIR with a GF Score™ of 52/100 and a GF Value™ of MXN764.28. The stock has 5 warning signs investors should review.

Vir Biotechnology has the Growth Rank of 1.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Vir Biotechnology Growth Rank Related Terms

MEX:VIR vs AVBP, XNCR, SEPN: Growth Rank Comparison

For the Biotechnology subindustry, Vir Biotechnology's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vir Biotechnology Growth Rank vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vir Biotechnology's Growth Rank distribution charts can be found below:

* The bar in red indicates where Vir Biotechnology's Growth Rank falls into.


MEX:VIR
52GF Score
Vir Biotechnology Inc MEX:VIR
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 1 mean?
Vir Biotechnology (MEX:VIR) has a Growth Rank of 1 as of Aug. 19, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Vir Biotechnology and its competitors. This is 50% below median its historical median of 2.00. Over the past decade, Vir Biotechnology's Growth Rank has ranged from 1.00 to 8.00.
Is Vir Biotechnology's Growth Rank too high?
Vir Biotechnology's current Growth Rank of 1 is 50% below median its 10-year median of 2.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 8.00. Overall, Vir Biotechnology has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does Vir Biotechnology's Growth Rank compare to AVBP and XNCR?
Vir Biotechnology's Growth Rank of 1 can be compared against companies in the Biotechnology industry. Historically, Vir Biotechnology's own Growth Rank has ranged from 1.00 to 8.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Biotechnology company?
A good Growth Rank depends on the Biotechnology industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Vir Biotechnology and its competitors. Vir Biotechnology's current Growth Rank is 1, which is 50% below median its own 10-year median of 2.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vir Biotechnology stock overvalued right now?
Vir Biotechnology (MEX:VIR) has a current Growth Rank of 1. The stock's GF Value™ is MXN764.28, compared to a current price of MXN170.00 — trading 77.8% below its estimated fair value. The current Growth Rank is 1, which is 50% below median its 10-year median of 2.00. Vir Biotechnology's overall GF Score™ is 52/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Vir Biotechnology (MEX:VIR), the current Growth Rank is 1 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vir Biotechnology (MEX:VIR) Overvalued in 2026?

Based on GuruFocus' analysis, Vir Biotechnology stock appears to be undervalued. The current stock price of MXN170.00 is trading 77.8% below its estimated GF Value™ of MXN764.28.

Key valuation signals for MEX:VIR:

  • Growth Rank: 1 (50% below median its 10-year median of 2.00)
  • GF Value™: MXN764.28 vs. price of MXN170.00 (77.8% below fair value)
  • GF Score™: 52/100 with 5 warning signs

No single metric tells the full story. See the MEX:VIR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vir Biotechnology Business Description

Other Exchanges VIR:USA
Address 1800 Owens Street, Suite 900, San Francisco, CA, USA, 94158
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.
52GF Score

Get the complete analysis for MEX:VIR

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN170.00
Price
MXN764.28
GF Value